Effect of ondansetron, a 5-HT3 receptor antagonist, on the dynamic association between bulimic behaviors and pain thresholds

Pain

Volumn 77, Issue 3, 1998, Pages 297-303

  Faris, Patricia L ^a,c   Won Kim, Suck ^a   Meller, William H ^a   Goodale, Robert L ^b   Hofbauer, Randall D ^a,c   Oakman, Scott A ^a,c   Howard, Lynn A ^a   Stevens, Eric R ^a,c   Eckert, Elke D ^a   Hartman, Boyd K ^a,c  

^a MAYO GRADUATE SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Bulimia nervosa; Ondansetron; Pressure pain detection; Vagus nerves

Indexed keywords

ONDANSETRON; PLACEBO; SEROTONIN 3 ANTAGONIST;

ADULT; ARTICLE; BULIMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEEDING BEHAVIOR; FEMALE; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; VAGUS NERVE; VOMITING;

ADULT; BULIMIA; FEEDING BEHAVIOR; FEMALE; HUMANS; MIDDLE AGED; NOCICEPTORS; ONDANSETRON; PAIN THRESHOLD; PHYSICAL STIMULATION; PRESSURE; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS; VAGUS NERVE; VOMITING;

EID: 18844474370     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00108-0     Document Type: Article

References (37)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, American Psychiatric Association, Washington DC, 1994.
2. Blackshaw L.A., Grundy D. Effects of 5-hydroxytryptamine on discharge of vagal mucosal afferent fibres from the upper gastrointestinal tract of the ferret. J. Auton. Nerv. Syst. 45:1993;41-50.
3. Cooper Z., Fairburn C. The eating disorder examination: a semi-structured interview for the assessment of the specific psychopathology of eating disorders. Int. J. Eating Disorders. 6:1987;1-8.
4. de Zwaan, M., Biener, D., Schneider, C. and Stacher, G., Relationship between thresholds to thermally and to mechanically induced pain in patients with eating disorders and healthy subjects, Pain, 67(2-3) (1996a) 511-512.
5. de Zwaan, M., Biener, D,. Bach, M., Wiesnagrotzki, S. and Stacher, G., Pain sensitivity, alexithymia, and depression in patients with eating disorders: are they related?, J. Psychosom. Res., 41 (1996b) 65-70.
6. Fairburn C.G., Beglin S.J. Studies of the epidemiology of bulimia nervosa. Am. J. Psych. 147:1990;401-408.
7. Faris P.L., Raymond N.C., de Zwaan M., Howard L.A., Eckert E.D., Mitchell J.E. Nociceptive, but not tactile, thresholds are elevated in bulimia nervosa. Biol. Psychiatry. 32:1992;462-466.
8. First, M.B., Spitzer, R.L., Gibbon, M.J. and Williams, B.W., Structured Clinical Interview for DSM-IV (SCID), Biometric Research, New York State Psychiatric Institute, New York, NY, 1994.
9. Fukui H., Yamamoto M., Sato S. Vagal afferent fibers and peripheral 5-HT3 receptors mediate cisplatin-induced emesis in dogs. Jpn. J. Pharmacol. 59:1992;221-226.
10. Galligan J.J. Electrophysiological studies of 5-hydroxytryptamine receptors on enteric neurons. Behav. Brain Res. 73:1996;199-201.
11. 3H]LY278584. Brain Res. 553(1):1991;149-154.
12. Gibbons R., Hedeker D., Waternaux C., Davis J. Random regression models: a comprehensive approach to the analysis of longitudinal psychiatric data. Psychopharmacol. Bull. 24(3):1988;438-443.
13. Gibbons R.D., Hedeker D., Elkin I., Waternaux C., Kraemer H.C., Greenhouse J.B., Shea M.T., Imber S.D., Sotsky S.M., Watkins J.T. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Arch. Gen. Psychiat. 50(9):1993;739-750.
14. Goddard C.V., McIntyre D.C., Leech C.K. A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol. 25:1969;295-330.
15. Grady T.A., Broocks A., Canter S.K., Pigott T.A., Dubbert B., Hill J.L., Murphy D.L. Biological and behavioral responses to D-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers. Psychiat. Res. 64:1996;1-10.
16. Hartman B.K., Faris P.L., Kim S.W., Raymond N.C., Goodale R.L., Eckert E.D. Ondansetron in bulimia nervosa. Arch. Gen. Psychiatry. 54(10):1997;969-970.
17. Hedeker, D. and Gibbons, R.D., MIXREG: a computer program for mixed-effects regression analysis with autocorrelated errors, Comp. Methods Prog. Biomed., 49 (1996) 229-252.
18. Herzog D.B., Copeland P.M. Bulimia nervosa - psyche and satiety. N. Engl. J. Med. 319:1988;716-718.
19. Kamato, T., Ito, H., Nagakura, Y., Nishida, A., Yuki, H., Yamano, M. and Miyata, K., Mechanisms of cisplatin- and m-chlorophenylbiguanide-induced emesis in ferrets, Eur. J. Pharmacol., 238(2/3) (1993) 369-376.
20. 3H]zacopride as radioligands. Synapse. 10(4):1992;271-281.
21. Lautenbacher S., Pauls A.M., Strian F., Pirke K.M., Krieg J.C. Pain perception in patients with eating disorders. Psychosomatic Med. 52(6):1990;673-682.
22. Lautenbacher, S., Barth, K., Friess, E., Strian, F., Pirke, K.M. and Krieg, J.C., Dieting and pain sensitivity: a validation of clinical findings, Physiol. Behav., 50(3) (1991a) 629-631.
23. Lautenbacher, S., Pauls, A.M., Strian, F., Pirke, K.M. and Krieg, J.C., Pain sensitivity in anorexia nervosa and bulimia nervosa, Biological Psychiatry, 29 (1991b) 1073-1078.
24. McKendall M.J., Haier R.J. Pain sensitivity and obesity. Psychiat. Res. 8:1983;119-125.
25. Meller, S.T., Lewis, S.J., Brody, M.J. and Gebhart, G.F., Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes, Brain Res., 585(1/2) (1992) 71-82.
26. Meller S.T., Lewis S.J., Ness T.J., Brody M.J., Gebhart G.F. Vagal afferent-mediated inhibition of a nociceptive reflex by intravenous serotonin in the rat. I. Characterization. Brain Res. 524(1):1990;90-100.
27. Miller A.D., Nonaka S. Mechanisms of vomiting induced by serotonin-3 receptor agonists in the cat: effect of vagotomy, splanchnicectomy or area postrema lesion. J. Pharmacol. Exp. Therapeutics. 260(2):1992;509-517.
28. Naranjo C.A., Bremner K.E. Clinical pharmacology of serotonin-altering medications for decreasing alcohol consumption. Alcohol Alcoholism. S2:1993;221-229.
29. Ohuoha, D.C., Knable, M.B., Wolf, S.S., Kleinman, J.E. and Hyde, T.M., The subnuclear distribution of 5-HT3 receptors in the human nucleus of the solitary tract and other structures of the caudal medulla, Brain Res., 637(1/2) (1994) 222-226.
30. Pauls A.M., Lautenbacher S., Strian F., Pirke K.M., Krieg J.C. Assessment of somatosensory indicators of polyneuropathy in patients with eating disorders. Eur. Arch. Psychiat. Clin. Neurosci. 241(1):1991;8-12.
31. Post R.M., Weiss S.R. A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures. Mol. Neurobiol. 13:1996;33-60.
32. Randich A., Maixner W. [D-Ala]methionine enkephalin-amide reflexively induces antinociception by activating vagal afferents. Pharmacol. Biochem. Behav. 21(3):1984;441-448.
33. Reynolds D.J., Barber N.A., Grahame S.D., Leslie R.A. Cisplatin-evoked induction of c-fos protein in the brainstem of the ferret: the effect of cervical vagotomy and the anti-emetic 5-HT3 receptor antagonist granisetron (BRL 43694). Brain Res. 565:1991;231-236.
34. Roggo A., Filippini L. Transmural esophagus perforation. Experiences with conservative treatment, Schweizerische Medizinische Wochenschrift. J. Suisse de Medecine. 119:1989;1257-1263.
35. Simpson K.H., Murphy P., Colthup P.V., Whelan P. Concentration of ondansetron in cerebrospinal fluid following oral dosing in volunteers. Psychopharmacol. (Berl.). 109(4):1992;497-498.
36. Smith G.P. Animal models of human eating disorders. Ann. N.Y. Acad. Sci. 575:1989;63-74.
37. Whipple B., Komisaruk B.R. Analgesia produced in women by genital self-stimulation. J. Sex Res. 24(1):1988;130-140.